
Clinical Trial Methodology
by Karl E. Peace; Ding-Geng (Din) ChenBuy New
Rent Textbook
Rent Digital
Used Textbook
We're Sorry
Sold Out
Summary
Table of Contents
Overview of Clinical Trial Methodology | |
Clinical Trials | |
Clinical Trial Methodology | |
Summary of Clinical Trial Methodology | |
Overview of the Drug Development Process and Regulation of Clinical Trials | |
Introduction | |
The Drug Development Process | |
History of Drug Regulation | |
Principles of Adequate and Controlled Investigations | |
Content and Format of the IND | |
Content and Format of the NDA | |
Organizational Structure of the FDA | |
The FDA Review Process | |
Labeling and the Package Insert | |
Pharmaceutical Company Organization and Role of the Biostatistician | |
Ethical Considerations in the Design and Conduct of Clinical Trials | |
Introduction | |
History and Evolution of Ethical Considerations in Clinical Trials: Key Milestones | |
Independent Review Boards | |
Clinical Trial Ethics: Who Should Practice? | |
Informed Consent, Sample Size, and Power | |
Common Ethical Principles of Various Codes and Regulations | |
Sample Size Considerations in Clinical Trials Pre-Market Approval | |
Introduction | |
Phases of Clinical Trials and Objectives | |
The Clinical Development Plan: Pre-Market Approval | |
Sample Size Requirements | |
Examples | |
Philosophical Issues | |
Sequential, Group Sequential, Stochastic Curtailment, and Adaptive Design Procedures in Clinical Trials | |
Introduction | |
Sequential Procedures | |
Group Sequential Procedures | |
Stochastic Curtailment | |
Adaptively Designed Clinical Trials | |
Biostatistical Aspects of the Protocol | |
The Background or Rationale | |
Objective | |
Plan of Study | |
Statistical Analysis Section | |
Administration | |
Protocol References Section | |
The Statistical Analysis Plan | |
Introduction | |
Protocol Objective | |
Efficacy Data Collected and Protocol Schema | |
Primary and Secondary Efficacy Endpoints | |
Objectives, Translated as Statistical Hypotheses | |
Protocol Design Features | |
Statistical Analyses | |
Pooling of Data from Multicenter Clinical Trials | |
Introduction | |
Multicenter Clinical Trial Experimental Setting | |
Pre-Study Planning | |
Multicenter Clinical Trial Conduct | |
Biostatistical Analysis | |
Validity of Statistical Inference | |
Introduction | |
Planning the Investigation | |
Conducting the Investigation | |
Statistical Analyses, Interpretation, and Inference | |
Reporting Results of Investigations | |
Bioequivalence Clinical Trials | |
Introduction | |
Absorption, Distribution, Metabolism, and Excretion (ADME) | |
Bioavailability | |
Factors That Affect Bioavailability | |
Blood Level Clinical Trials | |
Bioequivalence | |
Design of Bioequivalence Trials | |
Analysis of Bioequivalence Trials | |
Analysis of Ratios | |
Pharmacokinetic Models | |
Support of Bioequivalence Trials in the Pharmaceutical Industry | |
Examples | |
Dose and Frequency Determination from Phase II Clinical Trials in Stress Test-Induced Angina | |
Introduction | |
Overview of Response Surface Methodology | |
Full Quadratic Response Surface Model | |
Phase II Clinical Trial Program in Stress Test-Induced Angina | |
Confirmation of Clinically Optimal Dosing in the Treatment of Duodenal Ulcers: A Phase III Dose Comparison Trial | |
Introduction | |
Background | |
Objective | |
Designing and Planning the Investigation | |
Conducting the Investigation | |
Statistical Analyses | |
Other Considerations | |
Innovative Aspects of the Clinical Trial Program | |
Pivotal Proof-of-Efficacy Clinical Trials in the Prevention of NANSAID-Induced Gastric Ulceration | |
Introduction | |
Rationale | |
The Protocols | |
Monitoring and Data Management | |
FDA Meeting | |
Clinical Trials in the Treatment of Alzheimer's Disease Based upon Enrichment Designs | |
Introduction | |
Enrichment Design Clinical Trials | |
Objective | |
Primary Efficacy Endpoints | |
Sample Size Determination | |
Statistical Methods | |
Results | |
A Clinical Trial to Establish Reduction of CHD Risk | |
Introduction | |
Objective | |
Designing and Planning the Investigation | |
Conducting the Investigation | |
Data Management | |
Statistical Analyses | |
Results | |
Summary | |
Pivotal Proof-of-Efficacy Clinical Trials in the Treatment of Panic Disorder | |
Introduction | |
Design of Pivotal Proof-of-Efficacy Trials | |
Traditional Statistical Analysis Methods | |
Overview of Efficacy Results of the Two Trials | |
Alternative Design and Analysis Strategies | |
Combination Clinical Trials | |
Introduction | |
Two-by-Two Factorial Design | |
Effectiveness of the Combination | |
Contribution of Components to the Effectiveness of the Combination | |
Factorial Designs in Other Clinical Development Areas | |
Example 1 Actifed in the Treatment of SAR Following DESI Review | |
Example 2 Crossover Trial of Actifed in the Treatment of SAR | |
Example 3 Parallel Trial of Actifed in the Treatment of the Common Cold | |
Monitoring Clinical Trials for Adverse Events | |
Introduction | |
Designing for Safety: Antibiotic Rash Example | |
Designing for Safety: Hypokalemia Example | |
Designing for Safety: Hypertensive Rebound Example | |
Premarket Approval Trials: Designed for Efficacy | |
Premarket Approval Trials: Quality of Adverse Event Information | |
Monitoring for Safety | |
Statistical Methodology: Individual Trial | |
Example | |
Statistical Methodology: Across Trials | |
Index | |
References appear at the end of each chapter | |
Table of Contents provided by Publisher. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.